These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22388848)

  • 1. [Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data].
    Ferraro PM; D'Ovidio V; Bresci G; Astegiano M; Principi B; D'Inca' R; Testa R; Valpiani D; Guidi L; Armuzzi A; Costa F; Aratari A; Vecchi M; De Franchis R; Di Leo V; Ricci C; Riegler G; Colombo E; Repaci G; Lecis P; Silla M; Passalacqua S
    G Ital Nefrol; 2012; 29 Suppl 54():S144-6. PubMed ID: 22388848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
    D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
    Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
    Passalacqua S; Ferraro PM; Bresci G; D'Ovidio V; Astegiano M; Principi M; Testa R; D'Incà R; Valpiani D; Armuzzi A; Sablich R; Cavallaro F; Costa F; Di Leo V; Colombo E; Santini A; Aratari A; Lecis P; Saladino V; Riegler G; Marco M; Calella F; Ricci C; Guidi ML; Repaci G; Silla M
    J Clin Apher; 2011 Dec; 26(6):332-7. PubMed ID: 22072543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
    Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K
    Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of granulocyte and monocyte adsorption apheresis for ulcerative colitis: a meta-analysis.
    Yoshino T; Nakase H; Minami N; Yamada S; Matsuura M; Yazumi S; Chiba T
    Dig Liver Dis; 2014 Mar; 46(3):219-26. PubMed ID: 24268950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.
    Yamamoto T; Umegae S; Kitagawa T; Yasuda Y; Yamada Y; Takahashi D; Mukumoto M; Nishimura N; Yasue K; Matsumoto K
    Aliment Pharmacol Ther; 2004 Oct; 20(7):783-92. PubMed ID: 15379839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of granulocyte and monocyte adsorption apheresis on urinary albumin excretion and plasma endothelin-1 concentration in patients with active ulcerative colitis.
    Nakamura T; Kawagoe Y; Matsuda T; Ueda A; Ueda Y; Takahashi Y; Tanaka A; Koide H
    Blood Purif; 2004; 22(6):499-504. PubMed ID: 15528877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
    Kanke K; Nakano M; Hiraishi H; Terano A
    Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
    Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
    Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis Is Suitable for Elderly Patients With Active Ulcerative Colitis Taking no Corticosteroids or Biologics.
    Fukuchi T; Koga H; Kaichi S; Ishikawa A; Horita T; Araki R; Yokota A; Namba Y; Kyo M; Eguchi T; Shimazu K
    Ther Apher Dial; 2019 Jun; 23(3):224-232. PubMed ID: 31025824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease.
    Edfors K; Ståhlberg D; Söderman C
    Ther Apher Dial; 2016 Feb; 20(1):79-85. PubMed ID: 26841133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Granulocyte-monocyte apheresis for the treatment of inflammatory bowel disease].
    ; Passalacqua S; Ferraro PM
    G Ital Nefrol; 2012; 29 Suppl 54():S61-3. PubMed ID: 22388832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia.
    Ljung T; Thomsen OØ; Vatn M; Karlén P; Karlsen LN; Tysk C; Nilsson SU; Kilander A; Gillberg R; Grip O; Lindgren S; Befrits R; Löfberg R
    Scand J Gastroenterol; 2007 Feb; 42(2):221-7. PubMed ID: 17327942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent granulocyte and monocyte apheresis versus mercaptopurine for maintaining remission of ulcerative colitis: a pilot study.
    Sakuraba A; Sato T; Morohoshi Y; Matsuoka K; Okamoto S; Inoue N; Takaishi H; Ogata H; Iwao Y; Hibi T
    Ther Apher Dial; 2012 Jun; 16(3):213-8. PubMed ID: 22607563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The application of selectie granulocyte and monocyte apheresis in the treatment of ulcerative colitis].
    Liu ZF; Zheng HH; Jiang XL
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):444-446. PubMed ID: 28592046
    [No Abstract]   [Full Text] [Related]  

  • 20. Granulocyte and monocyte adsorption apheresis therapy modulates monocyte-derived dendritic cell function in patients with ulcerative colitis.
    Iwakami Y; Sakuraba A; Sato T; Takada Y; Izumiya M; Ichikawa H; Hibi T
    Ther Apher Dial; 2009 Apr; 13(2):138-46. PubMed ID: 19379153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.